Harrow Stock

Harrow Equity

The The Equity of Harrow (HROW) as of Aug 12, 2026 is 52.45 M USD. In the previous year, The Equity was 69.65 M USD — a change of -24.70% (lower).

Equity

52.45 MUSD

YoY

-24.70%

Last updated:

In 2026, Harrow's equity was 52.45 M USD, a -24.70% increase from the 69.65 M USD equity in the previous year.

Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Harrow's Equity

Harrow's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Harrow's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Harrow's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Harrow's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Harrow’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Harrow stock

The Equity of Harrow is 52.45 M USD in 2026.

The Equity of Harrow changed from 69.65 M USD to 52.45 M USD, representing a -24.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Harrow since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Harrow historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Harrow

All Key Metrics — Harrow